Clinical Study

Evaluation of X-Chromosome Inactivation Patterns in Patients with Acute Myeloid Leukemia during Remission

Table 2

Features of the patients who were followed after remission.

Patients number AgeDiagnosis (FAB) ClonalityDuration of following (month)CytogeneticsFlow cytometry

2640M3Mono.846XX, t(15; 17) (q22; q21) /46, XX Compatible with M3
2820M3Mono.1246XX, t(15; 17) (q22; q21) /46, XX Compatible with M3
3321M3Mono.646XX, t(15; 17) (q22; q21) ]/46, XX Compatible with M3
3543M3Mono.646XX, t(15; 17) (q22; q21) /46, XX Compatible with M3
3645M3Mono.646XX, t(15; 17) (q22; q21) /46, XX Compatible with M3
4021M3Poly.746XX, t(15; 17) (q22; q21) Compatible with M3
4320M2Poly.546XX, t(15; 17) (q22; q21) /46, XX Compatible with M2
4534M2Mono.4N.AN.A
4740M3Mono.646XX, t(8; 15; 17) (q24.10; q21)ort(8; 14)(q11; q32), t(15; 17) (q22; q21) /46, XX Compatible with M3
4820M3Poly.546XX, t(15; 17) (q22; q11–21) /46, XX Compatible with M3